Group One Trading’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-800
| Closed | -$142K | – | 8709 |
|
|
2025
Q3 | $142K | Hold |
800
| – | – | ﹤0.01% | 5006 |
|
|
2025
Q2 | $90.9K | Buy |
+800
| New | +$85.5K | ﹤0.01% | 5050 |
|
|
2024
Q4 | – | Sell |
-6,000
| Closed | -$601K | – | 7649 |
|
|
2024
Q3 | $601K | Sell |
6,000
-1,200
| -17% | -$121K | ﹤0.01% | 2721 |
|
|
2024
Q2 | $607K | Buy |
7,200
+400
| +6% | +$31.8K | ﹤0.01% | 2388 |
|
|
2024
Q1 | $497K | Buy |
6,800
+6,500
| +2,167% | +$479K | ﹤0.01% | 2724 |
|
|
2023
Q4 | $21.4K | Sell |
300
-22,500
| -99% | -$1.33M | ﹤0.01% | 5698 |
|
|
2023
Q3 | $1.37M | Buy |
22,800
+7,600
| +50% | +$500K | ﹤0.01% | 1973 |
|
|
2023
Q2 | $1.1M | Buy |
15,200
+5,100
| +50% | +$383K | ﹤0.01% | 2274 |
|
|
2023
Q1 | $743K | Buy |
10,100
+100
| +1% | +$7.11K | ﹤0.01% | 2395 |
|
|
2022
Q4 | $668K | Sell |
10,000
-6,030
| -38% | -$392K | ﹤0.01% | 2786 |
|
|
2022
Q3 | $861K | Sell |
16,030
-160
| -1% | -$9.41K | ﹤0.01% | 2728 |
|
|
2022
Q2 | $901K | Hold |
16,190
| – | – | ﹤0.01% | 2857 |
|
|
2022
Q1 | $1.14M | Sell |
16,190
-4,809
| -23% | -$349K | ﹤0.01% | 2959 |
|
|
2021
Q4 | $2.02M | Sell |
20,999
-13,305
| -39% | -$1.23M | ﹤0.01% | 2586 |
|
|
2021
Q3 | $2.98M | Sell |
34,304
-161
| -0.5% | -$12.5K | ﹤0.01% | 2243 |
|
|
2021
Q2 | $2.82M | Sell |
34,465
-70,532
| -67% | -$5.87M | ﹤0.01% | 2276 |
|
|
2021
Q1 | $9.98M | Buy |
104,997
+38,793
| +59% | +$3.67M | 0.01% | 944 |
|
|
2020
Q4 | $4.11M | Buy |
66,204
+41,838
| +172% | +$2.39M | 0.01% | 1430 |
|
|
2020
Q3 | $1.45M | Sell |
24,366
-111,729
| -82% | -$7.62M | ﹤0.01% | 1863 |
|
|
2020
Q2 | $9.5M | Sell |
136,095
-41,197
| -23% | -$2.61M | 0.04% | 465 |
|
|
2020
Q1 | $8.04M | Sell |
177,292
-143,629
| -45% | -$8.14M | 0.07% | 329 |
|
|
2019
Q4 | $20.9M | Buy |
320,921
+178,414
| +125% | +$11.9M | 0.14% | 137 |
|
|
2019
Q3 | $8.85M | Buy |
142,507
+24,686
| +21% | +$1.55M | 0.07% | 324 |
|
|
2019
Q2 | $8.39M | Buy |
117,821
+25,969
| +28% | +$1.91M | 0.08% | 297 |
|
|
2019
Q1 | $7.2M | Buy |
91,852
+72,616
| +378% | +$5.5M | 0.08% | 284 |
|
|
2018
Q4 | $1.63M | Buy |
19,236
+15,549
| +422% | +$1.66M | 0.01% | 1163 |
|
|
2018
Q3 | $631K | Sell |
3,687
-801
| -18% | -$121K | 0.01% | 2088 |
|
|
2018
Q2 | $580K | Buy |
4,488
+3,847
| +600% | +$429K | 0.01% | 2178 |
|
|
2018
Q1 | $66K | Sell |
641
-1,443
| -69% | -$143K | ﹤0.01% | 3510 |
|
|
2017
Q4 | $178K | Buy |
2,084
+1,603
| +333% | +$139K | ﹤0.01% | 2993 |
|
|
2017
Q3 | $41K | Sell |
481
-29,976
| -98% | -$2.37M | ﹤0.01% | 3737 |
|
|
2017
Q2 | $2.31M | Buy |
30,457
+27,251
| +850% | +$1.91M | 0.02% | 870 |
|
|
2017
Q1 | $212K | Sell |
3,206
-160
| -5% | -$10.5K | ﹤0.01% | 2482 |
|
|
2016
Q4 | $213K | Buy |
3,366
+3,206
| +2,004% | +$202K | ﹤0.01% | 2382 |
|
|
2016
Q3 | $10K | Sell |
160
-642
| -80% | -$47.1K | ﹤0.01% | 4047 |
|
|
2016
Q2 | $60K | Buy |
802
+481
| +150% | +$35.7K | ﹤0.01% | 3191 |
|
|
2016
Q1 | $21K | Hold |
321
| – | – | ﹤0.01% | 3717 |
|
|
2015
Q4 | $22K | Sell |
321
-1,763
| -85% | -$109K | ﹤0.01% | 3867 |
|
|
2015
Q3 | $111K | Sell |
2,084
-37,510
| -95% | -$2.28M | ﹤0.01% | 2968 |
|
|
2015
Q2 | $2.49M | Buy |
39,594
+33,022
| +502% | +$1.8M | 0.03% | 618 |
|
|
2015
Q1 | $316K | Sell |
6,572
-1,924
| -23% | -$73.7K | 0.01% | 1987 |
|
|
2014
Q4 | $282K | Buy |
+8,496
| New | +$276K | ﹤0.01% | 2019 |
|
|
2014
Q3 | – | Sell |
-12,343
| Closed | -$480K | – | 5312 |
|
|
2014
Q2 | $480K | Buy |
12,343
+160
| +1% | +$6.49K | 0.01% | 1675 |
|
|
2014
Q1 | $511K | Sell |
12,183
-29,976
| -71% | -$1.25M | 0.01% | 1631 |
|
|
2013
Q4 | $1.38M | Buy |
42,159
+17,954
| +74% | +$585K | 0.02% | 892 |
|
|
2013
Q3 | $654K | Sell |
24,205
-13,305
| -35% | -$374K | 0.01% | 1381 |
|
|
2013
Q2 | $876K | Buy |
+37,510
| New | +$675K | 0.02% | 913 |
|
Other funds holding LGND
VPM
VCM
NAMI
CC
Group One Trading's LGND Position: Q1 2026 in Review
Group One Trading reduced its Ligand Pharmaceuticals (LGND) stake by 43% in Q1 2026, selling an estimated $254K and leaving 1,669 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #3711.
Group One Trading first reported a position in LGND in Q3 2013 and has held it in 21 quarters since. The position peaked at $3.99M in Q1 2017. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.
- Group One Trading held 1,669 shares of Ligand Pharmaceuticals worth $333K as of Q1 2026.
- Group One Trading sold 1,284 Ligand Pharmaceuticals shares in Q1 2026, an estimated $254K.
- Ligand Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3711 holding.
- Group One Trading first reported a position in Ligand Pharmaceuticals in Q3 2013 and has held it in 21 quarters since.
- Group One Trading's Ligand Pharmaceuticals position peaked at $3.99M in Q1 2017.
- 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.